advisorsecurities master

IGCIGC Pharma, Inc.

CSNYSE American, LLC (XASE)·USD

Identity

Security key
16955
Ticker
IGC
Type
CSCommon Stock
Exchange
NYSE American, LLC(XASE)
Venue group
NYSE
Operating MIC
XNYS
Market
stocks
Locale
us
Currency
USD
Listed
2006-04-13
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
IGC

Detail

Enriched 2026-08-14 20:47

Market cap
$29,838,288
Shares outstanding (class)
100,091,317
Shares outstanding (weighted)
104,366,170
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
70
Location
POTOMAC, MD
Description

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data